Skip to product information
1 of 3

Melsmon Placenta Inj

Melsmon Placenta Inj

Regular price $600.00USD
Regular price Sale price $600.00USD
Sale Sold out
Shipping calculated at checkout.
(Melsmon Pharmaceutical Co Ltd, Japan)

Package details: Melsmon 50 vials X 2 ml each.

Active ingredient: human placenta hydrolysate, sodium hydroxide - to pH 7.0, water d / and less than 2 ml.
Melsmon is a Japanese ampoule solution for skin rejuvenation based on a human placenta extract. The product contains more than 100 active substances, including amino acids, mucopolysaccharides, vitamins, enzymes, minerals, etc. Melsmon launches rejuvenation processes at the cellular level. As a result, the skin looks younger and healthier. The product also has a positive effect on the body as a whole: it results in enhanced performance efficiency, reduced drowsiness, fatigue, and the level of stress.

Start of sales: in Japan after clinical trials (conducted throughout the country in 98 cases) in 1959, March.

Official Code in Japan: 3259600A1020, Certified in Japan, Korea, Russian and NIS

Major functions of Melsmon

- Strengthens the function of internal organs and promotes cells' rejuvenation,
- Stimulates haematopoietic function,
- Restores the normal function for hormone production,
- Enhances the growth of mammary gland,
- Improves circulation of blood,
- Accelerates skin regenerations after injuries.

Melsmon has significant visible whitening and firming effects on the skin.

- Increases light reflectance, inner "luminescence" of skin,
- Restoration of trophics, considerable reinnervation,
- Extension of tissue breathing 5-7 times,
- Eliminates hyper pigmentation,
- Intensive revascularization,
- Regeneration of epidermis cells.

The effect of placenta extracts is highly relies on the individual's age and health condition. Effects can be seed as fast as one week in some patiends and may take as much as 60 days in others.

Recommended Dosage: One ampoules/injection every 2-3 days for 1-2 months.

Not Advisable When:

Breast feeding.
Menstrual Period.
Patient with cardiovascular problem
View full details